Fig. 2From: Notch-based gene signature for predicting the response to neoadjuvant chemotherapy in triple-negative breast cancerPerformance of the Notch 5-TSPs signature in the testing sets. The signature includes five gene pairs that distinguish RD from pCR before initiating NACT in the two testing datasets (A, B). ROC (upper panel) and PRC (lower panel) curves were used to evaluate the performance. ROC Receiver operating characteristic curve. PRC Precision Recall Curve. AUC Area under the ROC curve. AUPRC Area Under the Precision Recall CurveBack to article page